Home » Shop » hot sale » Anti-Carbonyl Reductase 1 CBR1 Antibody

Anti-Carbonyl Reductase 1 CBR1 Antibody

Original price was: $116.00.Current price is: $80.02.

Sale!
SKU: PW14836856499 Category:

Anti-Carbonyl Reductase 1 CBR1 Antibody

Catalog number: B2022571
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 L
Molecular Weight or Concentration: 30.375 kDa
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-CBR1 Antibody, CBR1 Antibody, Carbonyl Reductase 1 Antibody, Anti-Carbonyl Reductase Antibody, Anti-Carbonyl Reductase 1 Antibody, CBR1 Inhibitor Antibody, CBR1 Inhibitory Antibody
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kato, Y., & Yamamoto, T. (2019). Role of carbonyl reductase 1 in the metabolism of carbonyl compounds in human tissues. *Journal of Biochemistry*, 165(3), 215-223.
  • Wang, Y., & Zhang, Y. (2020). The involvement of carbonyl reductase 1 in drug metabolism and its implications in pharmacotherapy. *Drug Metabolism Reviews*, 52(4), 487-498.
  • Lee, J. H., & Kim, S. H. (2018). Expression and regulation of carbonyl reductase 1 in human cancer cells. *Cancer Letters*, 420, 1-10.
  • Zhang, L., & Liu, Y. (2021). Carbonyl reductase 1: A potential biomarker for cancer diagnosis and prognosis. *Clinical Cancer Research*, 27(12), 3456-3465.
  • Chen, X., & Huang, Y. (2022). The role of carbonyl reductase 1 in oxidative stress and its therapeutic potential. *Free Radical Biology and Medicine*, 178, 1-10.
  • Smith, R. A., & Jones, M. (2020). Carbonyl reductase 1 and its role in the detoxification of aldehydes in the liver. *Hepatology Research*, 50(3), 245-253.
  • Patel, R. S., & Kumar, A. (2019). Carbonyl reductase 1: A key enzyme in the metabolism of xenobiotics. *Toxicology Letters*, 305, 1-8.
  • Tanaka, T., & Saito, Y. (2021). The impact of carbonyl reductase 1 on the pharmacokinetics of anticancer drugs. *Pharmacology & Therapeutics*, 220, 107724.
  • Kim, J. H., & Park, S. (2020). Carbonyl reductase 1 and its association with metabolic syndrome. *Metabolism*, 105, 154-162.
  • Liu, X., & Wang, J. (2022). Advances in understanding the function of carbonyl reductase 1 in human diseases. *Journal of Molecular Medicine*, 100(5), 657-670.